Cargando…

Ιmpact of sunitinib-induced hypothyroidism on survival of patients with metastatic renal cancer

BACKGROUND: Sunitinib plays an important role in managing the metastatic renal cell cancer (mRCC). Sunitinib-induced hypothyroidism is a common side-effect of the drug. There have been attempts to link hypothyroidism with a better clinical outcome in sunitinib-treated (mRCC) patients. Our aim was to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vasileiadis, Theofanis, Chrisofos, Michail, Safioleas, Michail, Kontzoglou, Konstantinos, Papazisis, Konstantinos, Sdrolia, Athina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492389/ https://www.ncbi.nlm.nih.gov/pubmed/31039771 http://dx.doi.org/10.1186/s12885-019-5610-8

Ejemplares similares

Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients
por: Buda-Nowak, Anna, et al.
Publicado: (2017)

Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
por: Kontovinis, Loukas F, et al.
Publicado: (2009)

Breast cancer incidence in Greek women in relation to ABO blood groups and Rh factor
por: Stamatakos, Michael, et al.
Publicado: (2009)

Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration
por: Bamias, A, et al.
Publicado: (2013)

The iMPACT project tracker and calorimeter
por: Mattiazzo, S, et al.
Publicado: (2017)

Brain natriuretic peptide precursor (NT-pro-BNP) levels predict for clinical benefit to sunitinib treatment in patients with metastatic renal cell carcinoma
por: Papazisis, Konstantinos T, et al.
Publicado: (2010)

MPact: the MIPS protein interaction resource on yeast
por: Güldener, Ulrich, et al.
Publicado: (2006)

Successful pregnancy after breast cancer therapy: dream or reality?
por: Kontzoglou, Konstantinos, et al.
Publicado: (2009)

Phylloides tumor of the breast: a rare neoplasm, though not that innocent
por: Stamatakos, Michael, et al.
Publicado: (2009)

Treatment of Advanced/Metastatic Melanoma in the United States and Western Europe: Results of the CancerMPact Survey
por: Hawthorne, Stephanie, et al.
Publicado: (2020)

Paraganglioma of the Urinary Bladder: A Case Report on a Rare and Unexpected Tumor Location
por: Kratiras, Zisis, et al.
Publicado: (2023)

Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
por: Gu, Cheng-Yuan, et al.
Publicado: (2021)

iMPACT: An Innovative Tracker and Calorimeter for Proton Computed Tomography
por: Mattiazzo, Serena, et al.
Publicado: (2018)

Calorimeter prototyping for the iMPACT project pCT scanner
por: Pozzobon, Nicola, et al.
Publicado: (2019)

Pott Puffy Tumor in Adults: The Τiming of Surgical Ιntervention
por: Sideris, Giorgos, et al.
Publicado: (2020)

Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
por: Motzer, R J, et al.
Publicado: (2013)

Patterns of Care and Outcomes for Non-Metastatic Prostate Cancer in the United States: Results of the CancerMPact(®) Survey 2018
por: de Sá Moreira, Eloisa, et al.
Publicado: (2021)

The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation
por: Wolter, P, et al.
Publicado: (2008)

nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACT trial
por: Tabernero, Josep, et al.
Publicado: (2017)

Erythema multiforme major induced by sunitinib for metastatic renal cell carcinoma
por: Watanabe, Daisuke, et al.
Publicado: (2019)

Induction of trismus by sunitinib and pazopanib in metastatic renal cell carcinoma
por: Iyer, Ridhima, et al.
Publicado: (2017)

Complete remission of metastatic renal cell carcinoma to the bone with sunitinib
por: Yoshimura, Akihiro, et al.
Publicado: (2020)

Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib
por: Mohammad, H., et al.
Publicado: (2021)

Metastatic Thymic Carcinoma with Long Survival After Treatment with Sunitinib
por: Cabezón-Gutiérrez, Luis, et al.
Publicado: (2018)

Macrocytosis during sunitinib treatment predicts progression-free survival in patients with metastatic renal cell carcinoma
por: Kucharz, Jakub, et al.
Publicado: (2016)

The ΙgΕ-epitome viewed through the eyes of human monoclonal ΙgΕ
por: Levin, Mattias, et al.
Publicado: (2014)

nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial
por: Tehfe, Mustapha, et al.
Publicado: (2016)

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
por: Hutson, T E, et al.
Publicado: (2014)

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma
por: Gilabert, M, et al.
Publicado: (2013)

Intolerance to Sunitinib Treatment in Hemodialysis Patients With Metastatic Renal Cell Carcinoma
por: Yildiz, Ibrahim, et al.
Publicado: (2014)

Clinical significance of sunitinib‐associated macrocytosis in metastatic renal cell carcinoma
por: Bourlon, Maria T., et al.
Publicado: (2016)

The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinib
por: Frees, Sebastian, et al.
Publicado: (2018)

Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma
por: Cella, D, et al.
Publicado: (2012)

Analyses of Potential Predictive Markers and Survival Data for a Response to Sunitinib in Patients with Metastatic Renal Cell Carcinoma
por: Dornbusch, Juana, et al.
Publicado: (2013)

Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib
por: Koutsoukos, Konstantinos, et al.
Publicado: (2017)

The incidence and mechanism of sunitinib-induced thyroid atrophy in patients with metastatic renal cell carcinoma
por: Shinohara, N, et al.
Publicado: (2011)

Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients
por: Ordu, Çetin, et al.
Publicado: (2016)

Erratum to: nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial
por: Tehfe, Mustapha, et al.
Publicado: (2016)

spheresDT/Mpacts-PiCS: cell tracking and shape retrieval in membrane-labeled embryos
por: Thiels, Wim, et al.
Publicado: (2021)

Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib
por: Billemont, B, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_bi9bqoifsji3aa7c4aff1jtkkv